Showing 61-70 of 3210 results for "".
Physician Spotlight: Gary Goldenberg, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-gary-goldenberg-md/20897/Perspective on the dermatologist's role in recommending lifestyle changes with patients.Women in Dermatology With Brooke Jackson, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-brooke-jackson-md/23218/Physician Spotlight: Désirée Ratner, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-desiree-ratner-md-1/23263/Women in Dermatology With Jeanine Downie, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-jeanine-downie-md/23130/Cosmeceutical Shopping with Erin Gilbert, MD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceutical-shopping-with-erin-gilbert-md/20958/Dr. Gilbert reveals her top 10 go-to cosmeceuticals.Women in Dermatology: Iris Rubin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-iris-rubin-md/23589/Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uEmerging Vitiligo Therapies
https://practicaldermatology.com/conferences/maui-derm-2022/emerging-vitiligo-therapies/20047/It’s really an exciting time to be treating vitiligo, says John E. Harris, MD, PhD. He reviews Phase 2 and 3 clinical trials for ruxolitinib, a topical JAK inhibitor, and the hope that the FDA could soon approve it for the treatment of vitiligo. He also discusses other possible targeted treatments iChanging Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysisSkin of Color Session: Dr. Harris
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/skin-of-color-session-dr-harris/32683/John E. Harris, MD, PhD, summarizes his vitiligo talk from the "Skin of Color Session" at Maui Derm 2025, during which he covered new therapeutic options for vitiligo as well as promising drugs in the pipeline and why they could be so impactful.